| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-02-01 | FY 2023
FILED 2024-02-03 |
|---|---|---|---|
| Revenue (Total Sales) | $22.75B | $21.13B | $20.38B |
| YoY Revenue Growth % | +7.7% | +3.7% | — |
| Gross Profit | $6.30B | $5.87B | — |
| Gross Margin % | 27.7% | 27.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.71B | $2.59B | $2.31B |
| Operating Margin % | 11.9% | 12.2% | 11.3% |
| Net Income (GAAP) | $2.15B | $2.09B | $1.87B |
| EBITDA (Normalized) | $3.36B | $3.16B | $3.04B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.03B | $2.36B | $2.51B |
| Capital Expenditures (CapEx) | $819.3M | $720.1M | $917.0M |
| Free Cash Flow (FCF) | $2.21B | $1.64B | $1.60B |
| FCF Margin % | 9.7% | 7.7% | 7.8% |
| Return on Invested Capital (ROIC %) | 81.9% | 89.1% | 7.4% |
| Cash & Short-Term Equivalents | $4.59B | $4.73B | — |
| Total Debt (Short + Long Term) | $1.02B | $1.52B | $9.55B |
| Total Stockholders' Equity | $6.19B | $5.51B | $19.59B |